Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia

British Journal of Haematology

Volumn 108, Issue 3, 2000, Pages 518-523

  Meijers, Joost C M ^a   Oudijk, Erik Jan D ^a   Mosnier, Laurent O ^a   Bos, Rogier ^b,c   Bouma, Bonno N ^a   Nieuwenhuis, H Karel ^a   Fijnheer, Rob ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b TNO   (Netherlands)

^c Pharming Group NV   (Netherlands)

Author keywords

Acute promyelocytic leukaemia; Coagulation; Fibrinolysis; Plasmin; TAFI

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN; ARGININE; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; LYSINE; PLASMIN; PLASMINOGEN; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN CLOT; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS; CARBOXYPEPTIDASE U; CARBOXYPEPTIDASES; CASE-CONTROL STUDIES; ENZYME ACTIVATION; ENZYME TESTS; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PLASMIN; THROMBIN;

EID: 0034117225     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01890.x     Document Type: Article

References (35)

1. Avvisati, G., Ten Cate, J.W., Sturk, A., Lamping, R., Petti, M.G. & Mandelli, F. (1988) Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia. British Journal of Haematology, 70, 43-48.
2. Avvisati, G., Ten Cate, J.W., Buller, H.R. & Mandelli, F. (1989) Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. Lancet, 2, 122-124.
3. Bajzar, L. & Nesheim, M. (1993) The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation. Journal of Biological Chemistry, 268, 8608-8616.
4. Bajzar, L., Manuel, R. & Nesheim, M.E. (1995) Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. Journal of Biological Chemistry, 270, 14477-14484.
5. Bajzar, L., Nesheim, M.E. & Tracy, P.B. (1996a) The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood, 88, 2093-2100.
6. Bajzar, L., Morser, J. & Nesheim, M. (1996b) TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. Journal of Biological Chemistry, 271, 16603-16608.
7. Barbui, T., Finazzi, G. & Falanga, A. (1998) The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood, 91, 3093-3102.
8. Bauer, K.A. & Rosenberg, R.D. (1984) Thrombin generation in acute promyelocytic leukemia. Blood, 64, 791-796.
9. Bennett, B., Booth, N.A., Croll, A. & Dawson, A.A. (1989) The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination. British Journal of Haematology, 71, 511-517.
10. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. British Journal of Haematology, 33, 451-458.
11. Bos, R., Laterveer-Vreeswijk, G.H., Lockwood, D., Szecwcyk, K. & Nieuwenhuizen, W. (1999) A new enzyme immunoassay for soluble fibrin in plasma with a high discriminating power for thrombotic disorders. Thrombosis and Haemostasis, 81, 54-59.
12. Bouma, B.N., Von dem Borne, P.A.K. & Meijers, J.C.M. (1998) Factor XI and protection of the fibrin clot against lysis - a role for the intrinsic pathway of coagulation in fibrinolysis. Thrombosis and Haemostasis, 80, 24-27.
13. Broze, Jr, G.J. & Higuchi, D.A. (1996) Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. Blood, 88, 3815-3823.
14. De Fouw, N.J., De Jong, Y.F., Haverkate, F. & Bertina, R.M. (1988) Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor - no evidence for a cofactor role of protein S. Thrombosis and Haemostasis, 60, 328-333.
15. De Fouw, N.J., Haverkate, F. & Bertina, R.M. (1990) Protein C and fibrinolysis: a link between coagulation and fibrinolysis. Advances in Experimental Medical Biology, 281, 235-243.
16. De Stefano, V., Teofili, L., Sica, S., Mastrangelo, S., Di Mario, A., Rutella, S., Salutari, P., Rumi, C., d'Onofrio, G. & Leone, G. (1995) Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia. Blood, 86, 3535-3541.
17. Dombret, H., Scrobohaci, M.L., Ghorra, P., Zini, J.M., Daniel, M.T., Castaigne, S. & Degos, L. (1993) Coagulation disorders associatedwith acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment. Leukemia, 7, 2-9.
18. Dombret, H., Scrobohaci, M.L., Daniel, M.T., Miclea, J.M., Castaigne, S., Chomienne, C., Fenaux, P. & Degos, L. (1995) In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy. Leukemia, 9, 19-24.
19. Eaton, D.L., Malloy, B.E., Tsai, S.P., Henzel, W. & Drayna, D. (1991) Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. Journal of Biological Chemistry, 266, 21833-21838.
20. Gralnick, H.R. & Sultan, C. (1975) Acute promyelocytic leukaemia: haemorrhagic manifestation and morphologic criteria. British Journal of Haematology, 29, 373-376.
21. Gresele, P., Momi, S., Berrettini, M., Nenci, G.G., Schwarz, H.P., Semeraro, N. & Colucci, M. (1998) Activated human protein C prevents thrombin-induced thromboembolism in mice - evidence that activated protein C reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. Journal of Clinical Investigation, 101, 667-676.
22. Hoegee de Nobel, E., Voskuilen, M., Briet, E., Brommer, E.J. & Nieuwenhuizen, W. (1988) A monoclonal antibody-based quantitative enzyme immunoassay for the determination of plasma fibrinogen concentrations. Thrombosis and Haemostasis, 60, 415-418.
23. Koppert, P.W., Kuipers, W., Hoegee de Nobel, E., Brommer, E.J., Koopman, J. & Nieuwenhuizen, W. (1987) A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma. Thrombosis and Haemostasis, 57, 25-28.
24. Koppert, P.W., Hoegee de Nobel, E. & Nieuwenhuizen, W. (1988) A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma. Thrombosis and Haemostasis, 59, 310-315.
25. Minnema, M.C., Friederich, P.W., Von Levi, M., dem Borne, P.A.K., Mosnier, L.O., Meijers, J.C.M., Biemond, B.J., Hack, C.E., Bouma, B.N. & Ten Cate, H. (1998) Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI - in vivo evidence for a role of factor XI as an anti-fibrinolytic factor. Journal of Clinical Investigation, 101, 10-14.
26. Mosnier, L.O., Von dem Borne, P.A.K., Meijers, J.C.M. & Bouma, B.N. (1998) Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation. Thrombosis and Haemostasis, 80, 829-835.
27. Redlitz, A., Nicolini, F.A., Malycky, J.L., Topol, E.J. & Plow, E.F. (1996) Inducible carboxypeptidase activity - a role in clot lysis in vivo. Circulation, 93, 1328-1330.
28. Tallman, M.S. & Kwaan, H.C. (1992) Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood, 79, 543-553.
29. Von dem Borne, P.A.K., Meijers, J.C.M. & Bouma, B.N. (1995) Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood, 86, 3035-3042.
30. Von dem Borne, P.A.K., Bajzar, L., Meijers, J.C.M., Nesheim, M.E. & Bouma, B.N. (1997) Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. Journal of Clinical Investigation, 99, 2323-2327.
31. Wang, W., Hendriks, D.F. & Scharpe, S.S. (1994) Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. Journal of Biological Chemistry, 269, 15937-15944.
32. Wang, W., Boffa, M.B., Bajzar, L., Walker, J.B. & Nesheim, M.E. (1998) A study of the mechanism of inhibition of fibrinolysis byactivated thrombin-activable fibrinolysis inhibitor. Journal of Biological Chemistry, 273, 27176-27181.
33. Warrell, R.P.J., de The, H., Wang, Z.Y. & Degos, L. (1993) Acute promyelocytic leukemia. New England Journal of Medicine, 329, 177-189.
34. Wijermans, P.W., Rebel, V.I., Ossenkoppele, G.J., Huijgens, P.C. &Langenhuijsen, M.M. (1989) Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: reversal of the bleeding disorder by cell differentiation. Blood, 73, 800-805.
35. Wilson, E.L., Jacobs, P. & Dowdle, E.B. (1983) The secretion of plasminogen activators by human myeloid leukemic cells in vitro. Blood, 61, 568-574.